Effectiveness of Transcranial Magnetic Stimulation (TMS) Therapy

Evidence for TMS in Major Depressive Disorder (MDD)

• The American College of Physicians recommends TMS for patients with major depressive disorder who have shown partial or no response to two or more adequate pharmacologic treatment trials, with response rates ranging from 29-48% and a number needed to treat of 3.4 to 9 patients for response and 5 to 7 patients for remission 1, 2
• The aggregate literature suggests that the benefits of repetitive TMS (rTMS) for treatment-resistant depression in improving symptoms and facilitating remission outweigh the harms, according to the American College of Physicians 2

Limitations and Considerations

• A recent RCT in a veteran population with high rates of comorbid PTSD and substance use disorders found no significant differences between rTMS and sham treatment, suggesting placebo effects may play an important role, as reported by the American College of Physicians 1
• Access to TMS treatment can be challenging as it requires frequent onsite visits (typically 5 sessions per week for 4-6 weeks), according to the American College of Physicians 2

TMS for Other Conditions

• There is insufficient evidence to make a recommendation for or against theta-burst stimulation (TBS), a variation of TMS that uses rapid, repetitive pulses, as stated by the American College of Physicians 1, 2
• Some evidence suggests TMS may have potential applications in substance use disorders by reducing craving and potentially improving cognitive control, according to the National Institute of Mental Health 3, 4

Combination Approaches

• TMS may be more effective when combined with behavioral interventions such as cognitive behavioral therapy (CBT), as reported by the National Institute of Mental Health 3, 5
• Some studies show promising results when TMS is combined with pharmacotherapy, such as nearly 50% of patients becoming abstinent from cigarettes when TMS is used with nicotine replacement therapy, according to the National Institute of Mental Health 3, 5

Effectiveness of Transcranial Magnetic Stimulation for Post-Stroke Depression and Cancer-Related Depression and Anxiety

Special Populations

• Transcranial magnetic stimulation reduces symptoms of post-stroke depression, according to the American Heart Association, with significant improvements in depression scores 6
• The National Comprehensive Cancer Network recommends psychotherapy with or without pharmacotherapy as first-line treatment for cancer patients with depression and anxiety, although TMS may be considered as an alternative treatment option, as suggested by the American Society of Clinical Oncology 7, 8

Duration of Response to Repetitive Transcranial Magnetic Stimulation (rTMS)

Acute Treatment Response Duration

• Response rates can be maintained for 3 to 6 months in addiction-related applications following a standard acute treatment course, according to Neuroscience and Biobehavioral Reviews 9, 10, 11
• Reduced cigarette consumption and nicotine dependence persisted for up to 6 months following 13 sessions of rTMS, as reported in Neuroscience and Biobehavioral Reviews 9, 10, 11
• Enhanced abstinence rates lasted up to 3 months following just 4 sessions of intermittent theta burst stimulation (iTBS) in smokers, as found in Neuroscience and Biobehavioral Reviews 9, 10, 11

Factors Affecting Response Duration

• At least 4-6 weeks of daily rTMS over the left dorsolateral prefrontal cortex (DLPFC) was required to induce significant clinical improvement compared to sham stimulation, according to Neuroscience and Biobehavioral Reviews 9, 10, 12
• Studies performing rTMS for only 3 weeks found no difference between active and sham treatment, suggesting insufficient treatment duration, as reported in Neuroscience and Biobehavioral Reviews 9, 10, 12
• The number of treatment sessions appears critical—protocols with 8-14 sessions or more showed better sustained outcomes, as found in Neuroscience and Biobehavioral Reviews 13

Follow-Up Data Limitations

• A significant limitation in the literature is that 71% of studies did not include any follow-up beyond the day of intervention, according to Neuroscience and Biobehavioral Reviews 13
• Only two studies included one-year follow-up, six studies had six-month follow-up, and four studies had three-month follow-up, as reported in Neuroscience and Biobehavioral Reviews 13

Maintenance Treatment Strategies

• Some protocols incorporate maintenance interventions twice weekly for 3 months following an acute treatment phase to extend response duration, as found in Neuroscience and Biobehavioral Reviews 14
• In alcohol dependency, twice-daily sessions with 20-minute intervals led to positive effects on relapse reduction and quality of life lasting up to 6 months, according to Neuroscience and Biobehavioral Reviews 10, 11, 12

Clinical Implications and Caveats

• Only highly motivated patients should be recruited for intensive treatment protocols given the daily treatment burden, as reported in Neuroscience and Biobehavioral Reviews 14
• The relatively large heterogeneity in stimulation technique, timing, repetition, and montage across studies precludes clear understanding of optimal protocols for sustained response, according to Neuroscience and Biobehavioral Reviews 10, 11, 12